- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vital Images launches cardiac software
Three-dimensional visualization developer Vital Images this month formally released VScore, a new coronary artery calcium scoring software package. Vital Images received 510(k) clearance from the Food and Drug Administration for VScore in June
Three-dimensional visualization developer Vital Images this month formally released VScore, a new coronary artery calcium scoring software package. Vital Images received 510(k) clearance from the Food and Drug Administration for VScore in June (SCAN 6/23/99). The product is the Minneapolis companys first add-on option for its Vitrea 1.2 workstation, launched in 1996 (SCAN 10/23/96).
VScore allows users to quantify calcium in the four major coronary arteries with CT image data, and can be used with electron beam computed tomography (EBCT) scanners sold by Imatron of South San Francisco, CA. The package can also be used with data collected from conventional helical CT scanner data and multislice units.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
